NF1 and malignant peripheral nerve sheath tumor: Such microdeletions are associated with an increased risk of MPNST [36], leading to a model in which a “third hit” in SUZ12 (the first two hits being the loss of NF1 and one copy of SUZ12 from a 17q11.2 microdeletion) drives transformation to MPNST [30].